oncocarta v.1 massarray system (Sequenom)
90
Structured Review
Sequenom
oncocarta v.1 massarray system
Oncocarta V.1 Massarray System, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray-system-1/massarray+oncocarta+mutation+profiler+panel/pm20815376-108-8-12
Average 90 stars, based on 1 article reviews
Oncocarta V.1 Massarray System, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray-system-1/massarray+oncocarta+mutation+profiler+panel/pm20815376-108-8-12
Average 90 stars, based on 1 article reviews
oncocarta v.1 massarray system - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Variant Assay:Article Title: Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples Article Snippet: .. Scheme year Sample type c.2369C>T p.(Thr790Met) variant allele frequency (%) Method used Laboratory Reason for technical failure 2013 Cell line 25 Cobas EGFR Mutation detection Test v1 (Roche) 1 Inconclusive result 2 No amplification MAD-EGFR mut (Master Diagnostica S. L.) 3 DNA concentration too low EGFR StripAssay (ViennaLab) 4 DNA concentration too low EGFR 29 Mutations Detection Kit (AmoyDx) 5 DNA quality too low EGFR Mutation Analysis Reagents (Applied Biosystems) 6 DNA concentration too low Therascreen EGFR RGQ PCR Kit (Qiagen DxS) 7 Insufficient tissue material for analysis Massarray 4 analyser (Sequenom) 8 DNA concentration too Mutagenesis:Article Title: Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples Article Snippet: .. Scheme year Sample type c.2369C>T p.(Thr790Met) variant allele frequency (%) Method used Laboratory Reason for technical failure 2013 Cell line 25 Cobas EGFR Mutation detection Test v1 (Roche) 1 Inconclusive result 2 No amplification MAD-EGFR mut (Master Diagnostica S. L.) 3 DNA concentration too low EGFR StripAssay (ViennaLab) 4 DNA concentration too low EGFR 29 Mutations Detection Kit (AmoyDx) 5 DNA quality too low EGFR Mutation Analysis Reagents (Applied Biosystems) 6 DNA concentration too low Therascreen EGFR RGQ PCR Kit (Qiagen DxS) 7 Insufficient tissue material for analysis Massarray 4 analyser (Sequenom) 8 DNA concentration too Amplification:Article Title: Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples Article Snippet: .. Scheme year Sample type c.2369C>T p.(Thr790Met) variant allele frequency (%) Method used Laboratory Reason for technical failure 2013 Cell line 25 Cobas EGFR Mutation detection Test v1 (Roche) 1 Inconclusive result 2 No amplification MAD-EGFR mut (Master Diagnostica S. L.) 3 DNA concentration too low EGFR StripAssay (ViennaLab) 4 DNA concentration too low EGFR 29 Mutations Detection Kit (AmoyDx) 5 DNA quality too low EGFR Mutation Analysis Reagents (Applied Biosystems) 6 DNA concentration too low Therascreen EGFR RGQ PCR Kit (Qiagen DxS) 7 Insufficient tissue material for analysis Massarray 4 analyser (Sequenom) 8 DNA concentration too Concentration Assay:Article Title: Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples Article Snippet: .. Scheme year Sample type c.2369C>T p.(Thr790Met) variant allele frequency (%) Method used Laboratory Reason for technical failure 2013 Cell line 25 Cobas EGFR Mutation detection Test v1 (Roche) 1 Inconclusive result 2 No amplification MAD-EGFR mut (Master Diagnostica S. L.) 3 DNA concentration too low EGFR StripAssay (ViennaLab) 4 DNA concentration too low EGFR 29 Mutations Detection Kit (AmoyDx) 5 DNA quality too low EGFR Mutation Analysis Reagents (Applied Biosystems) 6 DNA concentration too low Therascreen EGFR RGQ PCR Kit (Qiagen DxS) 7 Insufficient tissue material for analysis Massarray 4 analyser (Sequenom) 8 DNA concentration too Polymerase Chain Reaction:Article Title: Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples Article Snippet: .. Scheme year Sample type c.2369C>T p.(Thr790Met) variant allele frequency (%) Method used Laboratory Reason for technical failure 2013 Cell line 25 Cobas EGFR Mutation detection Test v1 (Roche) 1 Inconclusive result 2 No amplification MAD-EGFR mut (Master Diagnostica S. L.) 3 DNA concentration too low EGFR StripAssay (ViennaLab) 4 DNA concentration too low EGFR 29 Mutations Detection Kit (AmoyDx) 5 DNA quality too low EGFR Mutation Analysis Reagents (Applied Biosystems) 6 DNA concentration too low Therascreen EGFR RGQ PCR Kit (Qiagen DxS) 7 Insufficient tissue material for analysis Massarray 4 analyser (Sequenom) 8 DNA concentration too Sequencing:Article Title: Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples Article Snippet: .. Scheme year Sample type c.2369C>T p.(Thr790Met) variant allele frequency (%) Method used Laboratory Reason for technical failure 2013 Cell line 25 Cobas EGFR Mutation detection Test v1 (Roche) 1 Inconclusive result 2 No amplification MAD-EGFR mut (Master Diagnostica S. L.) 3 DNA concentration too low EGFR StripAssay (ViennaLab) 4 DNA concentration too low EGFR 29 Mutations Detection Kit (AmoyDx) 5 DNA quality too low EGFR Mutation Analysis Reagents (Applied Biosystems) 6 DNA concentration too low Therascreen EGFR RGQ PCR Kit (Qiagen DxS) 7 Insufficient tissue material for analysis Massarray 4 analyser (Sequenom) 8 DNA concentration too other:Article Title: FGFR1 is amplified during the progression of in situ to invasive breast carcinoma Article Snippet: Supporting this concept, Hernandez and colleagues recently performed comparative analyses of known cancer genes using microarray-based comparative genomic hybridization and Sequenom MassARRAY (OncoCarta Panel v 1.0, Sequenom, San Diego, CA, USA) in matched DCIS and adjacent invasive carcinomas, and suggested that although the modal populations of both components were similar at the genetic level, the progression from DCIS to invasive ductal carcinoma was driven in some cases by selection of nonmodal clones with specific genetic aberrations [ ]. Article Title: An anaplastic lymphoma kinase (ALK) immunohistochemistry negative but fluorescence in situ hybridization (FISH) positive lung adenocarcinoma is resistant to Crizotinib Article Snippet: Mutation profiling was performed using the Article Title: Potential pitfalls of mass spectrometry to uncover mutations in childhood soft tissue sarcoma: A report from the Children’s Oncology Group Article Snippet: All 52 cases were assayed using the Article Title: Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors Article Snippet: From those individuals with sufficient available archival tumor tissue, gene mutational analysis was carried out on DNA extracted from archival tumor samples using PyroMark ® PCR or Article Title: Low-risk DCIS. What is it? Observe or excise? Article Snippet: There is, however, increasing evidence that intratumoural genetic heterogeneity is present in some DCIS [ ]; in one small series, thorough analysis including microarray-based comparative genomic hybridization (aCGH), |